Andrew Dufresne helps clients protect and advance their interests in patent litigation at the trial and appellate levels. At any stage of a matter—from an anticipated dispute, through ongoing litigation, to a new engagement on appeal—Andy works to prepare and execute a strategy tailored to each client’s objectives. He has represented a range of clients, including Fortune 100 and 500 companies, smaller and emerging companies, and numerous universities. He earned a Ph.D. in molecular genetics and microbiology and brings first-hand technical knowledge and experience to matters in the life sciences.
Andy has considerable experience litigating before the U.S. Court of Appeals for the Federal Circuit, Patent Trial and Appeal Board (PTAB), and district courts. A former Federal Circuit law clerk, Andy has a deep understanding of appellate practice and procedure, and he has represented clients in numerous matters before the Federal Circuit and other appellate courts. He has also participated in all phases of IPR proceedings before the PTAB, including drafting petitions and other papers, conducting discovery, and presenting oral argument.
In addition, Andy has litigated several matters in federal district courts, where he has worked with numerous expert witnesses, taken and defended depositions of expert and fact witnesses, and drafted successful dispositive motions.
Andy has represented clients in a range of technology areas, including pharmaceuticals, biotechnology, electronics and computer software, as well as fitness and sports equipment.
In his active pro bono practice, Andy has successfully represented U.S. military veterans before the U.S. Court of Appeals for Veterans Claims and the Federal Circuit in cooperation with the Veterans Consortium Pro Bono Program.
IPR Practice: “Good Causes” and Responding to Patent Owners’ Preliminary Responses
We wondered if some “good causes” were more effective than others when seeking leave to reply to a patent owner’s preliminary response (POPR) before institution of an inter partes review proceeding. Our analysis looks at the top 10 “good cause” arguments and their connection to institution decisions.
Life Science Legal Report
Significant Patent Decisions and Developments Affecting The Life Sciences Industry
Professional Recognition
- Recognized by Best Lawyers: Ones to Watch for Litigation - Patent Law; Patent Law, 2021-2024
- Listed in Wisconsin Super Lawyers, Rising Star, 2019
Professional Leadership
-
Intellectual Property Owners Association, Amicus Brief Committee, Member
-
Federal Circuit Bar Association
- Board of Directors, Member
- Regional Programs Committee, Past Chair
- Mock Argument Committee, Past Vice Chair
Related Employment
- Adjunct Professor, Patent Litigation, Marquette University Law School
Clerkships
- Hon. Alan D. Lourie, U.S. Court of Appeals for the Federal Circuit